Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
4.000
+0.290 (7.82%)
Nov 4, 2024, 4:00 PM EST - Market closed
Cabaletta Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 23.55 | 19.24 | 14.84 | 13.82 | 12.72 | 7.19 | |
| Research & Development | 76.57 | 55.42 | 39.3 | 32.49 | 21.11 | 11.49 | |
| Operating Expenses | 100.12 | 74.66 | 54.14 | 46.31 | 33.83 | 18.68 | |
| Operating Income | -100.12 | -74.66 | -54.14 | -46.31 | -33.83 | -18.68 | |
| Interest & Investment Income | 10.14 | 6.99 | 1.16 | 0.02 | 0.49 | 1.74 | |
| EBT Excluding Unusual Items | -89.98 | -67.68 | -52.98 | -46.29 | -33.34 | -16.94 | |
| Pretax Income | -89.98 | -67.68 | -52.98 | -46.29 | -33.34 | -16.94 | |
| Net Income | -89.98 | -67.68 | -52.98 | -46.29 | -33.34 | -16.94 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 5.33 | |
| Net Income to Common | -89.98 | -67.68 | -52.98 | -46.29 | -33.34 | -22.27 | |
| Shares Outstanding (Basic) | 47 | 41 | 29 | 26 | 23 | 5 | |
| Shares Outstanding (Diluted) | 47 | 41 | 29 | 26 | 23 | 5 | |
| Shares Change (YoY) | 40.14% | 39.54% | 14.01% | 11.20% | 323.18% | 208.05% | |
| EPS (Basic) | -1.92 | -1.65 | -1.81 | -1.80 | -1.44 | -4.07 | |
| EPS (Diluted) | -1.92 | -1.65 | -1.81 | -1.80 | -1.44 | -4.07 | |
| Free Cash Flow | -75.66 | -54.24 | -48.83 | -35.28 | -27.41 | -16.74 | |
| Free Cash Flow Per Share | -1.61 | -1.32 | -1.66 | -1.37 | -1.18 | -3.06 | |
| EBITDA | -98.61 | -73.23 | -52.96 | -45.58 | -33.48 | -18.58 | |
| D&A For EBITDA | 1.51 | 1.43 | 1.18 | 0.73 | 0.35 | 0.1 | |
| EBIT | -100.12 | -74.66 | -54.14 | -46.31 | -33.83 | -18.68 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.